151 related articles for article (PubMed ID: 6318745)
1. Low infectivity of vesicular stomatitis virus (VSV) particles released from interferon-treated cells is related to glycoprotein deficiency.
Maheshwari RK; Husain MM; Friedman RM
Biochem Biophys Res Commun; 1983 Nov; 117(1):161-8. PubMed ID: 6318745
[TBL] [Abstract][Full Text] [Related]
2. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
[TBL] [Abstract][Full Text] [Related]
3. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of interferon action: inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human leukocyte interferon. I. Effect on early and late stages of the viral multiplication cycle.
Masters PS; Samuel CE
J Biol Chem; 1983 Oct; 258(19):12019-25. PubMed ID: 6311834
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of interferon action: inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human leukocyte interferon. II. Effect on viral macromolecular synthesis.
Masters PS; Samuel CE
J Biol Chem; 1983 Oct; 258(19):12026-33. PubMed ID: 6311835
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of interferon on glycoprotein and membrane protein of vesicular stomatitis virus released from murine and simian cells.
Drebot MA; Lee SH; Rozee KR
J Interferon Res; 1984; 4(2):167-72. PubMed ID: 6205101
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of interferon action. Interferon alpha inhibits vesicular stomatitis virus primary transcript accumulation in P1/eIF-2 alpha protein kinase-deficient human fibroblast cells.
Zhang XT; Samuel CE
J Biol Regul Homeost Agents; 1987; 1(4):157-65. PubMed ID: 2845723
[TBL] [Abstract][Full Text] [Related]
8. Effect of human interferon on vesicular stomatitis virus released from bovine embryonic kidney cells.
Harrell SA; Maheshwari RK; Mohanty SB; Friedman RM
Am J Vet Res; 1982 Apr; 43(4):565-8. PubMed ID: 6176154
[TBL] [Abstract][Full Text] [Related]
9. Interferon treatment inhibits glycosylation of a viral protein.
Maheshwari RK; Banerjee DK; Waechter CJ; Olden K; Friedman RM
Nature; 1980 Oct; 287(5781):454-6. PubMed ID: 6159539
[TBL] [Abstract][Full Text] [Related]
10. Infectivity-deficient vesicular stomatitis virus produced in the presence of interferon has a functional virion core.
Jay FT; Dawood MR; Luk SK
Can J Microbiol; 1989 Feb; 35(2):334-9. PubMed ID: 2472861
[TBL] [Abstract][Full Text] [Related]
11. Microinjected interferon does not promote an antiviral response in Hela cells.
Huez G; Silhol M; Lebleu B
Biochem Biophys Res Commun; 1983 Jan; 110(1):155-60. PubMed ID: 6301439
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of the interferon-mediated antiviral state to vesicular stomatitis virus in resting mouse peritoneal macrophages.
Di Francesco P; Coccia EM; Gessani S; Romeo G; Borghi P; Locardi C; Belardelli F
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1899-905. PubMed ID: 2544669
[TBL] [Abstract][Full Text] [Related]
13. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
Maheshwari RK; Friedman RM
J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
Maheshwari RK; Jay FT; Friedman RM
Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
[TBL] [Abstract][Full Text] [Related]
15. Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity.
Whitaker-Dowling P; Youngner JS
Virology; 1983 Nov; 131(1):128-36. PubMed ID: 6316646
[TBL] [Abstract][Full Text] [Related]
16. Interferon induces the production of membrane protein-deficient and infectivity-defective vesicular stomatitis virions through interference in the virion assembly process.
Jay FT; Dawood MR; Friedman RM
J Gen Virol; 1983 Mar; 64 Pt 3():707-12. PubMed ID: 6186764
[TBL] [Abstract][Full Text] [Related]
17. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
Dargan DJ; Galt CB; Subak-Sharpe JH
J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
[TBL] [Abstract][Full Text] [Related]
18. Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles.
Pattnaik AK; Wertz GW
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1379-83. PubMed ID: 1847519
[TBL] [Abstract][Full Text] [Related]
19. Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components.
Bishop DH; Repik P; Obijeski JF; Moore NF; Wagner RR
J Virol; 1975 Jul; 16(1):75-84. PubMed ID: 166210
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of vesicular stomatitis virus particles: implications for virion assembly.
Lodish HF; Porter M
J Virol; 1980 Jan; 33(1):52-8. PubMed ID: 6245248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
